US veterans with chronic cardiovascular conditions experiencing homelessness and unstable housing have lower outpatient care utilization.

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

NDAQ:HUMA) Humacyte Provides Update on Commercial Launch and Pricing of Symvess(TM) (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma ...

John Sroufe alleges a surgical team at Research Medical Center used a disinfectant he was allergic to while preparing him for heart surgery, causing respiratory failure and anaphylactic shock.

Regular exercise strengthens the heart muscle and makes the body more efficient at pulling oxygen out of the blood. It also ...

The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

Novant Health New Hanover Regional Medical Center Offers More to Community Through Collaboration As a longtime leader at ...

The company will use the proceeds to test its gene therapy XC001 in two Phase II studies involving patients with cardiovascular disease.

The following is a summary of “Percutaneous coronary intervention of the left main coronary artery bifurcation: Insights from the PROGRESS-BIFURCATION registry,” published in the December 2024 issue ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

Belarusian cardiologists work real miracles. What transformations in the medical sector does government support prompt?About fifty ...